Fungal infections of the genitourinary system: manifestations, diagnosis, and treatment.

Urol Clin North Am

Division of Urology, Maimonides Medical Center, Brooklyn, New York, USA.

Published: November 1999

AI Article Synopsis

  • Immunocompromised patients, including premature infants, the elderly, and HIV patients, face a heightened risk of fungal infections, which contribute to 8% of hospital-acquired infections.
  • Candidal species are the most common fungal pathogens, but other species like Aspergillus and Cryptococcus are also significant threats.
  • Environmental fungi such as Blastomyces, Coccidioides, and Histoplasma are increasing in aggressiveness towards vulnerable patients experiencing disseminated fungal infections.

Article Abstract

There is an increasing pool of immunocompromised patients who are at an increased risk to fungi infections, which now cause 8% of nosocomial infections. Premature infants and elderly, transplant, and HIV patients are prime candidates for invasive fungal infections. The genitourinary system can be a source or target of disseminated fungal infection. Although candidal species are the most frequent pathogen, other species such as aspergila, cryptoccoccus have become major pathogens. "Environmental fungi," which include blastomyces, coccidioides and histoplasma, have become more aggressive in the vulnerable patient.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0094-0143(05)70212-3DOI Listing

Publication Analysis

Top Keywords

fungal infections
8
infections genitourinary
8
genitourinary system
8
system manifestations
4
manifestations diagnosis
4
diagnosis treatment
4
treatment increasing
4
increasing pool
4
pool immunocompromised
4
immunocompromised patients
4

Similar Publications

Pediatric dermatology access is limited. Pediatric teledermatology (TD) opens the opportunity to explore diverse dermatological pathology promptly. Different TD modalities and providers may influence the consulting population.

View Article and Find Full Text PDF

The morbidity of oral disorders, including gingivitis, caries, endodontic-periodontal diseases, and oral cancer, is relatively high globally. Pathogenic cells are the root cause of many oral disorders, and oral therapies depend on eradicating them. Photodynamic therapy (PDT) has been established as a potential and non-invasive local adjuvant treatment for oral disorders.

View Article and Find Full Text PDF

Coronavirus disease 2019 (COVID-19) pandemic has been prevailing for more than a year, associated with an increased number of opportunistic invasive fungal infections in patients who have been critically ill or immunocompromised. In this retrospective study, details of various clinical specimens received from suspected patients of fungal infections were studied. Fungal cultures were positive in 64% (51 out of 79) of COVID-19-positive patients and 43% (163 out of 381) of COVID-19-negative patients during the second wave of COVID-19 in 2021.

View Article and Find Full Text PDF

An update on newer antifungals.

Expert Rev Anti Infect Ther

January 2025

3rd Department of Critical Care, Evgenidio Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Introduction: Fungal infections constitute a significant global health threat, with an estimated incidence of 6.5 million invasive fungal infections and 2.5 million associated deaths each year.

View Article and Find Full Text PDF

Sjogren's syndrome (SS) is a chronic inflammatory autoimmune disease characterized by exocrine gland dysfunction. Mucormycosis is a rare yet life-threatening opportunistic fungal infection caused by species, with a high mortality rate. In patients undergoing long-term immunosuppressive therapy or corticosteroid use, especially when compounded by conditions such as diabetes or hyperlipidemia, Mucor can become pathogenic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!